Onyx Biotec Limited (NSE:ONYX)

Revenue by Product

Financials in millions INR. Fiscal year is April - March.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Sterile Water for Injections	320.05M
Sterile Water for Injections Growth	-18.33%
Dry Powder Injections	205.35M
Dry Powder Injections Growth	7696.17%
Dry Powder Syrup	12.09M
Dry Powder Syrup Growth	4011.56%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
India	537.49M
India Growth	36.14%